RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FERRERO C
Collezione AOU San Luigi di Orbassano

Items : 4

Development and validation of an UHPLC-MS/MS method for ?(2)-agonists quantification in human urine and application to clinical samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2018 Feb 20;150:15-24. doi: 10.1016/j.jpba.2017.11.055. Epub 2017 Dec 1.

2018
AOU San Luigi di Orbassano

Bozzolino C; Leporati M; Gani F; Ferrero C; Vincenti M; Bozzolino C; Leporati M; Gani F; Ferrero C; Vincenti M;

Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Sep;89(3):350-6. doi: 10.1016/j.lungcan.2015.06.019. Epub 2015 Jun 26.

2015
AOU San Luigi di Orbassano

Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S;

The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders. in Journal of neurology / J Neurol. 2008 Sep;255(9):1315-23. doi: 10.1007/s00415-008-0879-6. Epub 2008 Sep 25.

2008
AOU San Luigi di Orbassano

Durelli L; Barbero P; Bergui M; Versino E; Bassano MA; Verdun E; Ferrero B; Rivoiro C; Ferrero C; Picco E; Ripellino P; Viglietti D; Giuliani G; Montanari E; Clerico M;

MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):646-51. doi: 10.1136/jnnp.2007.130229. Epub 2007 Nov 6

2008
AOU San Luigi di Orbassano

Durelli L; Barbero P; Bergui M; Versino E; Bassano MA; Verdun E; Rivoiro C; Ferrero C; Picco E; Ripellino P; Giuliani G; Montanari E; Clerico M; Durelli L; Barbero P; Bergui M; Versino E; Bassano MA; Verdun E; Rivoiro C; Ferrero C; Picco E; Ripellino P; Giuliani G; Montanari E; Clerico M;